Skip to main content
Clinical Trials/ACTRN12623001282673
ACTRN12623001282673
Not Yet Recruiting
N/A

The effect of a Pulmonary Rehabilitation programme on 10-year risk of fragile fracture (FRAX score) in patients with COPD.

Andreas Daskalakis0 sites24 target enrollmentDecember 8, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Andreas Daskalakis
Enrollment
24
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 8, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Andreas Daskalakis

Eligibility Criteria

Inclusion Criteria

  • Greek patients (male and female aged 55\-80 years) with stable COPD stage I\-VI from the region os Attica, Greece, who visit outpatient department of Sotiria Hospital of Chest Diseases in Athens, Greece.

Exclusion Criteria

  • Patients with the follow criteria will be excluded from the trial:
  • a) Anti\-osteoporotic drug therapy up to three years before randomisation
  • b) Per os or intravenous corticosteroid therapy up to three months before randomisation
  • c) Charlson Comorbidity Index (CCI) \>5
  • d) Thyroid disorders (untreated hyperthyroidism, over\-treated hypothyroidism, primary hyperparathyroidism)
  • e) Excessive alcohol intake
  • f) Rheumatoid arthritis
  • g) Coeliac disease

Outcomes

Primary Outcomes

Not specified

Similar Trials